BIPH:OTO-Biophan Techs Inc (USD)

COMMON STOCK | Medical Instruments & Supplies | OTC Pink

Last Closing

USD 17.55

Change

0.00 (0.00)%

Market Cap

USD 0.19M

Volume

3.89K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Biophan Technologies Inc develops and markets cutting-edge technologies for the medical device industry. It develops biomedical devices that improve the delivery of healthcare.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-05 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
BDX Becton Dickinson and Company

N/A

USD 66.12B
ALC Alcon AG

N/A

USD 44.24B
HYB New America High Income Closed..

N/A

USD 35.93B
RMD ResMed Inc

N/A

USD 32.13B
WST West Pharmaceutical Services I..

N/A

USD 24.28B
BAX Baxter International Inc

N/A

USD 17.27B
TFX Teleflex Incorporated

N/A

USD 10.04B
ATR AptarGroup Inc

N/A

USD 9.81B
STVN Stevanato Group SpA

N/A

USD 5.45B
BLCO Bausch + Lomb Corp

N/A

USD 5.28B

ETFs Containing BIPH

DFNS:SW VanEck Defense ETF A USD .. 8.11 % 0.00 %

N/A

USD 0.69B
DXIF:CA Dynamic Active Internatio.. 6.71 % 0.00 %

N/A

CAD 4.90M
EXH4:F iShares STOXX Europe 600 .. 5.26 % 0.00 %

N/A

USD 0.21B
EXH4:XETRA iShares STOXX Europe 600 .. 5.26 % 0.00 %

N/A

USD 0.16B
DXG:CA Dynamic Active Global Div.. 5.14 % 0.82 %

N/A

CAD 0.67B
E40:PA BNP Paribas Easy CAC 40®.. 5.10 % 0.00 %

N/A

USD 0.32B
XEYX:XETRA BNP Paribas Easy CAC 40®.. 5.10 % 0.00 %

N/A

USD 0.32B
C40:PA Amundi Index Solutions - .. 5.08 % 0.00 %

N/A

USD 1.01B
GC40:F Amundi Index Solutions - .. 5.08 % 0.00 %

N/A

USD 0.91B
GC40:XETRA Amundi Index Solutions - .. 5.08 % 0.00 %

N/A

USD 0.91B
C4D:PA Amundi Index Solutions - .. 5.08 % 0.00 %

N/A

USD 0.03B
ASWC:XETRA HANetf ICAV - Future of D.. 4.97 % 0.00 %

N/A

USD 0.38B
ESIN:F Ishares VI PLC - Ishares .. 4.24 % 0.00 %

N/A

USD 0.16B
ESIN:XETRA Ishares VI PLC - Ishares .. 4.24 % 0.00 %

N/A

USD 0.16B
NDUS:LSE SPDR® MSCI Europe Indust.. 4.23 % 0.00 %

N/A

USD 0.35B
STQ:PA SPDR® MSCI Europe Indust.. 4.23 % 0.00 %

N/A

USD 0.35B
SPYQ:F SSgA SPDR ETFs Europe II .. 4.23 % 0.00 %

N/A

USD 0.35B
SPYQ:XETRA SPDR® MSCI Europe Indust.. 4.23 % 0.00 %

N/A

USD 0.31B
ESIN:LSE iShares MSCI Europe Indus.. 4.14 % 0.00 %

N/A

USD 0.17B
DX2G:XETRA Xtrackers - CAC 40 UCITS .. 4.05 % 0.00 %

N/A

USD 0.12B
CAC:PA Lyxor UCITS CAC 40 (DR) D.. 4.02 % 0.00 %

N/A

USD 3.58B
CACC:PA Lyxor CAC 40 (DR) UCITS E.. 4.02 % 0.00 %

N/A

USD 0.27B
CACX:LSE Lyxor CAC 40 (DR) UCITS E.. 4.01 % 0.00 %

N/A

USD 3.61B
EWQ iShares MSCI France ETF 3.92 % 0.47 %

N/A

USD 0.65B
IS3U:F iShares IV Public Limited.. 3.73 % 0.00 %

N/A

USD 0.11B
IS3U:XETRA iShares MSCI France UCITS 3.73 % 0.00 %

N/A

USD 0.11B
BDIV:CA Brompton Global Dividend .. 3.45 % 0.96 %

N/A

CAD 0.09B
IQQG:F iShares Public Limited Co.. 3.42 % 0.00 %

N/A

USD 0.33B
IQQG:XETRA iShares EURO Total Market.. 3.42 % 0.00 %

N/A

USD 0.29B
IDJG:LSE iShares EURO Total Market.. 3.40 % 0.00 %

N/A

USD 0.33B
FCSI:CA Franklin ClearBridge Sust.. 3.09 % 0.00 %

N/A

CAD 4.26M
JIG JPMorgan International Gr.. 2.73 % 0.00 %

N/A

USD 0.09B
GWT:PA Lyxor Index Fund - Lyxor .. 2.70 % 0.00 %

N/A

USD 0.15B
LGWT:F Lyxor Index Fund - Lyxor .. 2.70 % 0.00 %

N/A

USD 0.20B
LGWT:XETRA Lyxor Index Fund - Lyxor .. 2.70 % 0.00 %

N/A

USD 0.20B
CGGO Capital Group Global Grow.. 2.65 % 0.00 %

N/A

USD 3.61B
VVGM:XETRA VanEck Morningstar Global.. 2.18 % 0.00 %

N/A

USD 0.07B
GOAT:LSE VanEck Morningstar Global.. 2.15 % 0.00 %

N/A

USD 0.07B
GOGB:LSE VanEck Morningstar Global.. 2.15 % 0.00 %

N/A

USD 0.07B
ULVM VictoryShares US Value Mo.. 1.35 % 0.20 %

N/A

USD 0.16B
AVSD American Century ETF Trus.. 0.62 % 0.00 %

N/A

USD 0.14B
EDGF:CA Brompton European Dividen.. 0.00 % 0.00 %

N/A

CAD 0.02B

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange (OTC Pink)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.59% 78% C+ 63% D
Dividend Return 1.86% 100% F 73% C
Total Return 6.45% 78% C+ 67% D+
Trailing 12 Months  
Capital Gain 10.90% 83% B 58% F
Dividend Return 3.95% 89% A- 58% F
Total Return 14.85% 89% A- 58% F
Trailing 5 Years  
Capital Gain N/A 100% F 100% F
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A 100% F 100% F
Average Annual (5 Year Horizon)  
Capital Gain 73,599.16% 100% F 100% F
Dividend Return 73,601.28% 100% F 100% F
Total Return 2.12% 90% A- 48% F
Risk Return Profile  
Volatility (Standard Deviation) N/A 5% F N/A F
Risk Adjusted Return 31.72% 63% D 54% F
Market Capitalization 0.19M 6% D- N/A F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative earnings

The company had negative total earnings in the most recent four quarters.